Chills, loss of appetite, headache and muscle aches are found to be the new symptoms related to the novel coronavirus, reveals a study published by the Imperial College London.
Based on a survey of more than 1 million people between June 2020 and January 2021, the study said the new symptoms were in addition to the "classic" symptoms of the virus which are already included in the National Health Service (NHS) guidance, such as fever, new persistent cough, loss of sense of smell and/or taste, reports Xinhua news agency.
Can Biomarkers Determine Who's at Risk for Severe Covid-19 Symptoms?
Biomarkers help to know why some people affected with Covid-19 experience only mild, flu-like symptoms, while others suffer life-threatening respiratory problems, vascular dysfunction and tissue damage.
Advertisement
‘Currently, the U.K is the fourth highest cases of coronavirus in the world after the US, India and Brazil.’
Tweet it Now
There was some variation in symptoms depending on age, but chills were associated with Covid-19 across all age groups, said the study released by the REACT (Real-time Assessment of Community Transmission) team at the Imperial College London.
The more symptoms people showed, the more likely they were infected by the virus, it further revealed.
However, around 60 percent of infected people did not report any symptoms at all in the week leading up to their test, according to the research.
![What Spares Women from Severe COVID-19 Symptoms?]( "What Spares Women from Severe COVID-19 Symptoms?")
The hormone estrogen in women plays a protective role by lowering the levels of the angiotensin-converting enzyme2 or ACE2 in the heart and other organs. The ACE2 is the coronavirus's cellular receptor and is responsible for allowing the virus to enter into the organs and cause infection.
The study comes as the overall coronavirus case tally in the UK has increased to 3,996,833 as of Thursday morning, while the death toll stood at 115,068.
The country's infection tally is currently the fourth highest in the world after the US, India and Brazil, while the death toll is the fifth largest after the US, Brazil, Mexico and India.
So far, more than 12.6 million people in the UK have received the first jab of the coronavirus vaccine.
Source: IANS
However, around 60 percent of infected people did not report any symptoms at all in the week leading up to their test, according to the research.
What Spares Women from Severe COVID-19 Symptoms?
The hormone estrogen in women plays a protective role by lowering the levels of the angiotensin-converting enzyme2 or ACE2 in the heart and other organs. The ACE2 is the coronavirus's cellular receptor and is responsible for allowing the virus to enter into the organs and cause infection.
Advertisement
The study comes as the overall coronavirus case tally in the UK has increased to 3,996,833 as of Thursday morning, while the death toll stood at 115,068.
The country's infection tally is currently the fourth highest in the world after the US, India and Brazil, while the death toll is the fifth largest after the US, Brazil, Mexico and India.
So far, more than 12.6 million people in the UK have received the first jab of the coronavirus vaccine.
Source: IANS
New Devices Can Detect COVID-19 Symptoms, Predict Diagnosis
Wearable devices can help find COVID-19 cases earlier compared to traditional diagnostic methods and can help track and improve management of the disease.
Advertisement
 Indigestion Drug may Reduce COVID-19 Symptoms in Mild to Moderate DiseaseA widely available and inexpensive drug that is used to ease the symptoms of indigestion may prove a worthy contender for treating COVID-19 infection. | Advertisement
|
Advertisement
Recommended Readings
Latest Coronavirus News
A larger dose of dexamethasone (12 mg) appeared to be less effective than the standard dose (6 mg) for COVID-19 patients in India.
New study explores how COVID-19 vaccination might have spared a generation of American children from the enduring health challenges and expenses linked to premature birth.
Recent study reveals the immune response in adults after reducing the standard COVID-19 booster vaccine.
India's COVID case count reached 450.01 million (4.50 crore), with the administration of 2.21 billion (220.67 crore) COVID vaccine doses.
COVID-19 is a significant cause of hospitalization and mortality, especially among older adults and those with specific underlying health issues.